Neuroscience Market Size, Share, Growth Report 2026-2034

Market Overview

The global neuroscience market reached USD 37.1 Billion in 2025 and is projected to grow to USD 48.6 Billion by 2034, exhibiting a CAGR of 3.07% during the forecast period 2026-2034. Market expansion is driven by factors such as the increasing prevalence of neurological disorders, rising investments in research and development, and technological advancements in neuroimaging tools. Growing awareness of mental health issues and supportive government policies further facilitate growth. More details can be found in the Neuroscience Market report.

Study Assumption Years

• Base Year: 2025
• Historical Year/Period: 2020-2025
• Forecast Year/Period: 2026-2034

Neuroscience Market Key Takeaways

• The global neuroscience market size was valued at USD 37.1 Billion in 2025.
• The market is expected to exhibit a CAGR of 3.07% during 2026-2034.
• The forecast period spans from 2026 to 2034.
• Rising occurrence of neurological disorders, including epilepsy and Alzheimer's, is driving demand for treatments.
• Governments are investing in research and fostering collaborations between industries and academia.
• Technological advancements like AI and neuroimaging innovations enhance diagnostic and treatment capabilities.
• North America holds the largest market share due to its strong healthcare system and R&D investments.

Sample Request Link: https://www.imarcgroup.com/request?type=report&id=5133&flag=E

Market Growth Factors

Increasing Prevalence of Neurological Disorders

Neurological conditions such as Alzheimer's, Parkinson's, and epilepsy are rising worldwide, contributing substantially to market growth. For example, Alzheimer's cases in the US are projected to reach 13 million by 2050, driven by an aging population prone to neurodegenerative diseases. This trend accelerates demand for advanced diagnostic tools and effective treatment strategies, fostering intensified research into the biological mechanisms of these disorders.

Rising Investment in Neuroscience Research and Development

There is a surge in funding from public institutions and private enterprises targeting fundamental brain research and advanced technological development like brain mapping. Government agencies, philanthropic organizations, and private biotech and pharmaceutical companies are investing heavily in new drugs and therapies. This investment also strengthens the consumables segment with products such as patient monitors and injectors, enhancing neurological care efficiency.

Technological Advancements in Neuroimaging Tools

Advances in technologies including MRI, PET, and EEG have improved diagnosis and monitoring of neurological disorders with higher resolution and faster imaging speeds. The emergence of neuro-microscopy, with ultra-miniature electronic microscopes developed by companies like Danaher Corporation and Carl Zeiss AG, is transforming the field by enabling detection and potential reversal of neurological damage. AI and machine learning integrations further increase diagnostic accuracy and efficiency.

Market Segmentation

Breakup by Component:

• Instruments and Consumables: Representing the largest segment, this includes advanced diagnostic and surgical tools. Growth is fueled by precision instruments, high-throughput consumables, and expanding applications in genomic and proteomic research. Rising healthcare expenditure and regulations on certified instruments and sterile consumables positively influence this segment.
• Software and Services

Breakup by Technology:

• Brain Imaging: Holds the largest market share due to demand for accurate, early detection of neurological disorders like Alzheimer's and Parkinson's. Technological advancements in MRI, PET, and CT imaging have enhanced resolution and sensitivity, while AI and machine learning improve diagnosis.
• Neuro-Microscopy
• Electrophysiology
• Neuroproteomic Analysis
• Animal Behaviour Analysis
• Others

Breakup by End User:

• Hospitals: Demand driven by specialized healthcare services, advanced technologies, and patient care improvements. Expansions in surgical procedures and chronic disease management contribute to growth.
• Diagnostic Laboratories: Growth fueled by the need for early, accurate diagnosis of diseases using advanced technologies such as molecular diagnostics and next-generation sequencing.
• Research and Academic Institutes: Expansion supported by funding, collaborations with hospitals and diagnostic labs, and growing research scope.
• Others

Breakup by Region:

• North America: Dominates the market due to a high prevalence of chronic diseases, R&D investments, and the presence of leading companies focused on neurological devices.
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Regional Insights

North America leads the global neuroscience market, holding the largest share. Its dominance stems from investments in research and development, a high incidence of neurological disorders, and a robust healthcare infrastructure. For instance, CERENOVUS introduced the EMBOGUARD catheter for ischemic stroke in 2022, illustrating innovation in the region. The Asia Pacific region, benefiting from initiatives like China's USD 746 Million "China Brain Project," is poised for the fastest growth.

Recent Developments & News

In 2021, Blackrock Neurotech developed a wireless brain-computer interface (BCI) system enabling real-time neural activity monitoring without wired connections, improving patient comfort during studies. In 2022, Kernel launched the Kernel Flow, a non-invasive brain recording device using time-domain functional near-infrared spectroscopy technology to measure brain activity with high spatial and temporal resolution, enhancing accessibility for clinical and consumer neuroscience applications.

Key Players

• Alpha Omega Engineering
• Biobserve GmbH
• Blackrock Neurotech
• Doric Lenses Inc.
• General Electric Company
• Kernel
• Laserglow Technologies
• Mightex Systems
• NeuroNexus Technologies Inc.
• Noldus Information Technology B.V.
• Plexon Inc.
• Prizmatix Ltd.
• Siemens AG

Customization Note:

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: [email protected],

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302